Alcyomics is advertising a job opportunity for an early stage researcher (ESR) as part of a larger consortium to be funded by the Marie Sklodowska- Curie Innovative Training Network "BioRapid". More information can be found on the BioRapid website- www.bio- rapid.eu
Job description: Rapid detection of immunogenicity and adverse reactions to new compounds by in vitro assaying.
ESR will be involved in predicting sensitivity and potency of novel compounds using an in vitro human skin explant assay and correlate results with toxicity and modelling assessments. ESR will use ALC's novel Skimune™ assay methodology, based on the use of culturing autologous dendritic cells, with the compound of interest and incubating with autologous T cells which in turn are added to autologous skin.